|
English
|
正體中文
|
简体中文
|
2817115
|
|
???header.visitor??? :
27653800
???header.onlineuser??? :
574
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"choi hi"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally) 1 View [10|25|50] records per page
國家衛生研究院 |
2020-08-11 |
PT320, sustained-release exendin-4, mitigates L-DOPA-Induced dyskinesia in a rat 6-Hydroxydopamine model of Parkinson’s disease
|
Yu, SJ;Chen, S;Yang, YY;Glotfelty, EJ;Jung, J;Kim, HK;Choi, HI;Choi, DS;Hoffer, BJ;Greig, NH;Wang, Y |
國家衛生研究院 |
2018-07-16 |
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease
|
Chen, S;Yu, SJ;Li, Y;Lecca, D;Glotfelty, E;Kim, HK;Choi, HI;Hoffer, BJ;Greig, NH;Kim, DS;Wang, Y |
國家衛生研究院 |
2018-07-16 |
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease [Erratum: Scientific Reports. 2018 Jul 16;8:Article number 10722.]
|
Chen, S;Yu, SJ;Li, Y;Lecca, D;Glotfelty, E;Kim, HK;Choi, HI;Hoffer, BJ;Greig, NH;Kim, DS;Wang, Y |
國家衛生研究院 |
2017-09 |
A new treatment strategy for Parkinson's disease through the gut-brain axis: The glucagon-like peptide-1 receptor pathway
|
Kim, DS;Choi, HI;Wang, Y;Luo, Y;Hoffer, BJ;Greig, NH |
Showing items 1-4 of 4 (1 Page(s) Totally) 1 View [10|25|50] records per page
|